Trimetazidine and nicorandil decrease the increment of serum creatinine in patients with normal or slightly decreased renal function after undergoing elective percutaneous coronary intervention

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Professor Fengshuang An

Shandong University Qilu Hospital, Jinan (China)

6 More presentations in this session

Presentation thumbnail

Impact of chronic kidney disease on clinical outcomes in patients with unprotected left main coronary artery disease: insights from a large-sized all-comers registry

Assistant Professor D. Kim (Daejeon, KR)

Abstract Slides

Presentation thumbnail

Safety of emergency pretreatment regimen for contrast allergy before percutaneous coronary intervention for ST-elevation myocardial infarction

Doctor K. Jha (Danville, US)

Presentation thumbnail

Clinical outcomes of dialysis patients treated with current generation DES for left main distal bifurcation

Doctor Y. Watanabe (Matsudo, JP)

Abstract Slides

Presentation thumbnail

Evidence-practice gap in the preprocedural risk assessment for contrast-induced acute kidney injury

Doctor S. Shoji (Durham, US)

Abstract Slides

Presentation thumbnail

Proenkephalin as a new glomerular filtration marker for rule-out of sustained kidney injury after cardiac catheterization: main results from the prospective PANCAKE study

Doctor J. Geng (Hamburg, DE)

Access the full session

Session thumbnail

Poster Session 7 - Coronary Intervention

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Session

Cath lab tsunami: managing complications

Congress Presentation

Percutaneous intervention is better than surgery in real life for most patients: pro

Congress Session

PCI complications: the lyrics from my worst nightmares

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources